98 related articles for article (PubMed ID: 10524572)
1. Three-dimensional structure of the micro-blood vessels in thyroid tumors analyzed by immunohistochemistry coupled with image analysis.
Hama Y; Suzuki K; Shingu K; Fujimori M; Kobayashi S; Usuda N; Amano J
Thyroid; 1999 Sep; 9(9):927-32. PubMed ID: 10524572
[TBL] [Abstract][Full Text] [Related]
2. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
4. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms.
Kavantzas N; Tseleni-Balafouta S; Davaris P
J Exp Clin Cancer Res; 2002 Jun; 21(2):247-54. PubMed ID: 12148586
[TBL] [Abstract][Full Text] [Related]
5. Recurrent thyroid cancers have more peritumoural lymphatic vasculature than nonrecurrent thyroid cancers.
Hakala T; Sand J; Kellokumpu-Lehtinen PL; Huhtala H; Leinonen R; Kholová I
Eur J Clin Invest; 2014 Sep; 44(9):825-32. PubMed ID: 25047155
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltration in pediatric thyroid carcinomas.
Van Savell H; Hughes SM; Bower C; Parham DM
Pediatr Dev Pathol; 2004; 7(5):487-92. PubMed ID: 15547772
[TBL] [Abstract][Full Text] [Related]
7. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between cytology and histology in thyroid pathology. Case 2. Possible malignant lesion (insular carcinoma/poorly differentiated follicular carcinoma)].
Cochand-Priollet B
Ann Pathol; 2009 Apr; 29(2):91-4. PubMed ID: 19364580
[No Abstract] [Full Text] [Related]
9. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of thyroid gland angiomatoid tumors.
Cutlan RT; Greer JE; Wong FS; Eltorky M
Exp Mol Pathol; 2000 Oct; 69(2):159-64. PubMed ID: 11001864
[TBL] [Abstract][Full Text] [Related]
12. Intravascular Kaposi's-like spindle cell proliferation of the capsular vessels of follicular-derived thyroid carcinomas.
Baloch ZW; LiVolsi VA
Mod Pathol; 1998 Oct; 11(10):995-8. PubMed ID: 9796729
[TBL] [Abstract][Full Text] [Related]
13. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
14. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 is a presurgical marker of human thyroid carcinoma.
Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
[TBL] [Abstract][Full Text] [Related]
17. Histological and functional correlation of thyroid carcinoma by immunohistochemistry.
Prathiba D; Rao KR; Madhavan M
Indian J Pathol Microbiol; 1990 Jan; 33(1):35-40. PubMed ID: 2394474
[TBL] [Abstract][Full Text] [Related]
18. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
Cvejic D; Savin S; Paunovic I; Tatic S; Havelka M; Sinadinovic J
Anticancer Res; 1998; 18(4A):2637-41. PubMed ID: 9703921
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
Tuccari G; Barresi G
Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
